These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21297267)

  • 61. Melatonin protects SH-SY5Y neuroblastoma cells from calyculin A-induced neurofilament impairment and neurotoxicity.
    Li SP; Deng YQ; Wang XC; Wang YP; Wang JZ
    J Pineal Res; 2004 Apr; 36(3):186-91. PubMed ID: 15009509
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The Role of Berberine in the Multi-Target Treatment of Senile Dementia.
    Huang M; Chen S; Liang Y; Guo Y
    Curr Top Med Chem; 2016; 16(8):867-73. PubMed ID: 26311424
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The neuroprotective effects of ginsenosides on calcineurin activity and tau phosphorylation in SY5Y cells.
    Tu LH; Ma J; Liu HP; Wang RR; Luo J
    Cell Mol Neurobiol; 2009 Dec; 29(8):1257-64. PubMed ID: 19517226
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation.
    Yang CC; Kuai XX; Li YL; Zhang L; Yu JC; Li L; Zhang L
    Evid Based Complement Alternat Med; 2013; 2013():108486. PubMed ID: 24454482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer's disease.
    Wang L; Zhou BQ; Li YH; Jiang QQ; Cong WH; Chen KJ; Wen XM; Wu ZZ
    Neural Regen Res; 2023 Jan; 18(1):226-232. PubMed ID: 35799547
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correction: Berberine Attenuates Axonal Transport Impairment and Axonopathy Induced by Calyculin A in N2a Cells.
    Liu X; Zhou J; Abid MD; Yan H; Huang H; Wan L; Feng Z; Chen J
    PLoS One; 2016; 11(3):e0152609. PubMed ID: 27010719
    [No Abstract]   [Full Text] [Related]  

  • 67. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synthetic and Natural Bioactive Molecules in Balancing the Crosstalk among Common Signaling Pathways in Alzheimer's Disease: Understanding the Neurotoxic Mechanisms for Therapeutic Intervention.
    Shah AJ; Mir PA; Adnan M; Patel M; Maqbool M; Mir RH; Masoodi MH
    ACS Omega; 2023 Oct; 8(43):39964-39983. PubMed ID: 37929080
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Bioassays guided isolation of berberine from Berberis lycium and its neuroprotective role in aluminium chloride induced rat model of Alzheimer's disease combined with insilico molecular docking.
    Ismail H; Khalid D; Waseem D; Ijaz MU; Dilshad E; Haq IU; Bhatti MZ; Anwaar S; Ahmed M; Saleem S
    PLoS One; 2023; 18(11):e0286349. PubMed ID: 37910530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease.
    Vrabec R; Blunden G; Cahlíková L
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901826
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease.
    Ye XW; Wang HL; Cheng SQ; Xia LJ; Xu XF; Li XR
    Front Aging Neurosci; 2022; 14():890046. PubMed ID: 35795239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Berberine: A Promising Treatment for Neurodegenerative Diseases.
    Cheng Z; Kang C; Che S; Su J; Sun Q; Ge T; Guo Y; Lv J; Sun Z; Yang W; Li B; Li X; Cui R
    Front Pharmacol; 2022; 13():845591. PubMed ID: 35668943
    [TBL] [Abstract][Full Text] [Related]  

  • 73. History in Perspective: The prime pathological players and role of phytochemicals in Alzheimer's disease.
    Sajad M; Kumar R; Thakur SC
    IBRO Neurosci Rep; 2022 Jun; 12():377-389. PubMed ID: 35586776
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases.
    Kong YR; Tay KC; Su YX; Wong CK; Tan WN; Khaw KY
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33573300
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuroprotective effects of berberine in animal models of Alzheimer's disease: a systematic review of pre-clinical studies.
    Yuan NN; Cai CZ; Wu MY; Su HX; Li M; Lu JH
    BMC Complement Altern Med; 2019 May; 19(1):109. PubMed ID: 31122236
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The total alkaloids from
    Li JC; Shen XF; Shao JA; Tao MM; Gu J; Li J; Huang N
    Drug Des Devel Ther; 2018; 12():2695-2706. PubMed ID: 30214157
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glycoside hydrolase family 18 and 20 enzymes are novel targets of the traditional medicine berberine.
    Duan Y; Liu T; Zhou Y; Dou T; Yang Q
    J Biol Chem; 2018 Oct; 293(40):15429-15438. PubMed ID: 30135205
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential.
    Fan D; Liu L; Wu Z; Cao M
    Curr Neuropharmacol; 2019; 17(6):563-579. PubMed ID: 29676231
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation.
    Yang Y; Jia X; Feng J; Wang Z; Cao Y; Liu J; Li H
    Evid Based Complement Alternat Med; 2017; 2017():5934254. PubMed ID: 29422936
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of berberine in Alzheimer's disease.
    Cai Z; Wang C; Yang W
    Neuropsychiatr Dis Treat; 2016; 12():2509-2520. PubMed ID: 27757035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.